Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Conflicts with teachers are risk factor for school shootings

  • New study throws into question long-held belief about depression

  • Alcohol-dependence gene linked to neurotransmitter

  • Xenon exposure shown to erase traumatic memories

  • Social class makes a difference in how children tackle classroom problems

  • Inside the Teenage Brain: New Studies Explain Risky Behavior

  • Three-quarters of depressed cancer patients do not receive treatment for depression; new approach could transform care

  • Baicalin suppresses iron accumulation after substantia nigra injury

  • Factors predicting functional recovery of upper limb after peripheral nerve injuries

  • Collaborative care intervention improves depression among teens

  •